Skip to content
Disclosery

StepStone Group LP

Follow

13F filer, CIK 1502287, La Jolla, CA

StepStone Group LP reported $114,361,937 across 14 holdings for the quarter ended 2024-12-31, in a 13F-HR filed 2025-02-13. Its ten largest share positions make up 98.29% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950123-25-001948

Period
2024-12-31
Reported value
$114M
Holdings
14
Top 10 weight
98.29%
New
4
Sold out
4

Largest buys vs the previous quarter

SecurityShares changeApprox. value
OKURnew+491,938$4.23M
COINnew+13,281$3.3M
SENTINELONE INCnew+35,326$784K
METCnew+3,787$38.9K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
DUN & BRADSTREET HLDGS INCexited-13,219,351-$152M
RBLXexited-466,666-$20.7M
ROCKET LAB USA INCexited-1,936,599-$18.8M
FRSHexited-141,735-$1.63M
NEUEHEALTH INCreduced-2,103-$15.6K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q4 2024

Share positions as resolved from 13F-HR 0000950123-25-001948, largest first. % of portfolio is the value over $114,361,937, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
MONEYLION INCMONEYLION INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 622,931 shares; 2024Q4: 622,931 shares 622,931$53.6M46.85%0
PATHUIPATH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,286,527 shares; 2024Q4: 1,286,527 shares 1,286,527$16.4M14.3%0Timeline
TRDAENTRADA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 761,277 shares; 2024Q4: 761,277 shares 761,277$13.2M11.51%0Timeline
DKNGDRAFTKINGS INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 321,804 shares; 2024Q4: 321,804 shares 321,804$12M10.47%0Timeline
OKURONKURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 491,938 shares 491,938$4.23M3.7%newTimeline
NEUEHEALTH INCNEUEHEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 527,350 shares; 2024Q4: 525,247 shares 525,247$3.9M3.41%-2,103
PHATPHATHOM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 422,085 shares; 2024Q4: 422,085 shares 422,085$3.43M3%0Timeline
COINCOINBASE GLOBAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 13,281 shares 13,281$3.3M2.88%newTimeline
HILLEVAX INCHILLEVAX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 826,569 shares; 2024Q4: 826,569 shares 826,569$1.71M1.5%0
SENTINELONE INCSENTINELONE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 35,326 shares 35,326$784K0.69%new
VACASA INCVACASA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 147,261 shares; 2024Q4: 147,261 shares 147,261$722K0.63%0
TNYATENAYA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 462,163 shares; 2024Q4: 462,163 shares 462,163$661K0.58%0Timeline
GROVGROVE COLLABORATIVE HOLD INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 380,383 shares; 2024Q4: 380,383 shares 380,383$529K0.46%0Timeline
METCRAMACO RES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 3,787 shares 3,787$38.9K0.03%newTimeline

Sold out in Q4 2024

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
DUN & BRADSTREET HLDGS INCDUN & BRADSTREET HLDGS INC13,219,351$152Mshares
RBLXROBLOX CORP466,666$20.7Mshares
ROCKET LAB USA INCROCKET LAB USA INC1,936,599$18.8Mshares
FRSHFRESHWORKS INC141,735$1.63Mshares

How Q4 2024 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000950123-25-001948 base2025-02-13acceptance time not in the bulk data set